Canaccord Genuity Reiterates a 'Buy' on Dendreon (DNDN); Expecting Wins on CMS Decision and New Facility Approval
Tweet Send to a Friend
Canaccord Genuity reiterates a 'Buy' on Dendreon (NASDAQ: DNDN), PT $65.
Canaccord analyst, George Farmer, said, "We are buyers of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst, George Farmer, said, "We are buyers of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
